Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Results from the ARTEMIS DISK Global AntifungalSurveillance Study: a 6.5-Year Analysis of Susceptibilitiesof Candida and Other Yeast Species to Fluconazole andVoriconazole by Standardized Disk Diffusion Testing
2005
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors
2020
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
2014
Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists
2005
Abnormal Blood Flow and Red Blood Cell Deformability in Severe Malaria
2000
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Candidemia at a Tertiary-Care Hospital: Epidemiology, Treatment, Clinical Outcome and Risk Factors for Death
2002
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index
2020
Hepatitis C Virus Infection
2001 Standout
Global trends in emerging infectious diseases
2008 StandoutNature
Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy
2002
Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
2009
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
2003
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Chronic Liver Disease in Ethiopia with a Particular Focus on the Etiological Spectrums: A Systematic Review and Meta‐Analysis of Observational Studies
2021
Etiopathogenesis of acute hepatic failure: Eastern versus Western countries
2002
The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C
2000
Drug-Induced Hepatotoxicity
2003 Standout
Should Vascular Catheters Be Removed from All Patients with Candidemia? An Evidence-Based Review
2002
Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials
2010
Antecedent liver disease and drug toxicity
1999
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon
2003
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Dynamical features of thePlasmodium falciparumribosome during translation
2015 StandoutNobel
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
Candidemia in cancer patients: Impact of early removal of non-tunneled central venous catheters on outcome
2009
The pathogenic basis of malaria
2002 StandoutNature
Tipranavir
2008
Acute liver failure
2010
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Global burden of liver disease: 2023 update
2023 Standout
Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly
2012
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Neutrophils: Cinderella of innate immune system
2010
Hepatitis C Virus Infection and Bone Marrow Transplantation: A Cohort Study With 10–Year Follow–Up
1999
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
2008 Standout
Acute Hepatitis E Virus Infection Presenting as a Prolonged Cholestatic Jaundice
2001
Two Cases of Fungemia due to Candida lusitaniae and a Literature Review
2002
Treatment of Multidrug-Resistant Tuberculosis
1993
Treatment-related risk factors for hospital mortality in Candida bloodstream infections*
2008
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
Candida lusitaniaeInfections in the Era of Fluconazole Availability
2003
European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region
2002
RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)
2003
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Epstein–Barr Virus Infection
2000 Standout
3d Transition Metals for C–H Activation
2018 Standout
Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C.
1993 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Malaria: Mechanisms of Erythrocytic Infection and Pathological Correlates of Severe Disease
2006
Acute Myeloid Leukemia
2015 Standout
Primary Biliary Cirrhosis
1987 Standout
Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain
2013
Autoreactivity against biliary tract antigens in primary biliary cirrhosis
1985
On the Mechanism of Hydrolysis of Phosphate Monoesters Dianions in Solutions and Proteins
2006 StandoutNobel
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus
1994 StandoutNobel
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
1997
Testing for Hepatitis C Virus Infection Should Be Routine for Persons at Increased Risk for Infection
2004
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment
2021
Invasive Candidiasis
2015 Standout
Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1999 Standout
Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines.
1987
Ras-catalyzed hydrolysis of GTP: a new perspective from model studies.
1996
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Epidemiology and surveillance of autoimmune hepatitis in Asia
2022
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
HOW NEUTROPHILS KILL MICROBES
2005 Standout
Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002
2004
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
Guidelines for Treatment of Candidiasis
2004 Standout
Candidemia in Finland, 1995–1999
2003
Works of Sandro Vento being referenced
Transmission of HIV-Associated Tuberculosis to Healthcare Workers
1993
Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults
2006
Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C
1998
Infections and solid organ transplant rejection: a cause-and-effect relationship?
2002
Lung infections after cancer chemotherapy
2008
The bacterium that could cause cancer
2009
Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital
2000
Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
2003
Tipranavir
2005
Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals
1995
Sequential studies of pre‐S2 antigenemia and anti‐pre‐S2 antibodies in relation to viral replication in acute hepatitis B followed from the early incubation phase
1988
Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals
1991
Pentoxifylline as a Supportive Agent in the Treatment of Cerebral Malaria in Children
1995
T-lymphocyte sensitization to hepatocyte antigens in autoimmune chronic active hepatitis and primary biliary cirrhosis
1986
Liver cirrhosis in sub-Saharan Africa: neglected, yet important
2018
Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus
1996
ANTIGEN SPECIFIC SUPPRESSOR CELL FUNCTION IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
1984
T Lymphocyte Sensitization to Hbcag and T Cell–Mediated Unresponsiveness to Hbsag in Hepatitis B Virus–Related Chronic Liver Disease
1985